ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,558, issued on Aug. 12, was assigned to Emory University (Atlanta).

"Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections" was invented by Christina Gavegnano (Decatur, Ga.) and Raymond F. Schinazi (Miami).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds, compositions, and methods of treatment and prevention of HIV infection are disclosed. The compounds are pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidine JAK inhibitors. Combinations of these JAK inhibitors and additional antiretroviral compounds, such as NRTI, NNRTI, integrase inhibitors, entry inhibitors, protease inhibitors, and the like, are ...